Diagnosing Dupuytren’s contracture usually doesn’t require complex testing—in most cases, a simple physical examination of the hand is enough to identify the condition and understand its severity.
Introduction: Who Should Undergo Diagnostics
If you notice unusual changes in your hands, it may be time to seek diagnostic evaluation. Dupuytren’s contracture often announces itself quietly, beginning with small lumps or thickened areas in the palm that you might initially dismiss as harmless. However, these early signs can progress over time, eventually affecting how you use your hands in daily life.[1]
You should consider seeking diagnostics if you observe firm lumps forming under the skin of your palm, particularly near the base of your fingers. These lumps, known as nodules, might feel tender at first or remain painless. Over time, you may notice that your skin appears dimpled or puckered around these areas, as if something beneath is pulling it inward.[2]
It’s especially important to consult a healthcare provider when you experience difficulty straightening one or more fingers. This inability to fully extend your fingers signals that the condition may be advancing. Many people notice this problem when they try to place their hand flat on a table and find they cannot do so—a simple home test that often prompts them to seek medical attention.[5]
You might also find everyday activities becoming challenging. Tasks like putting on gloves, placing your hands in pockets, shaking hands, or gripping objects may become uncomfortable or awkward. These functional limitations are strong indicators that diagnostic evaluation is advisable.[1]
Certain individuals should be particularly vigilant about seeking diagnostics. If you are a man over 40, have Northern European or Scandinavian ancestry, or have family members who developed this condition, you face higher risk. People with diabetes, epilepsy, or those who use alcohol regularly should also monitor their hands closely for early signs. Because the condition often affects both hands and tends to progress slowly over months or years, early diagnosis can help you understand what to expect and plan appropriate intervention.[2]
Classic Diagnostic Methods
Diagnosing Dupuytren’s contracture is typically straightforward and relies primarily on physical examination rather than sophisticated technology. Your healthcare provider can usually identify the condition simply by looking at and feeling your hands. This approach makes diagnosis accessible and eliminates the need for expensive or invasive testing in most situations.[9]
During the physical examination, your doctor will carefully inspect both of your hands, even if you only notice symptoms in one. This is because Dupuytren’s contracture commonly affects both hands, though not necessarily at the same time or to the same degree. The examination involves comparing your two hands side by side to identify any differences in appearance or function.[9]
Your healthcare provider will look for visible signs on your palms. These include firm lumps or nodules beneath the skin, usually located near the base of the fingers where they meet the palm. The skin over these areas may appear dimpled, puckered, or drawn inward, creating small pits on the palm’s surface. As the condition advances, thick bands or cords of tissue may become visible, running from the palm into one or more fingers.[6]
The examination also includes palpation, which means your doctor will press on different parts of your hands and fingers with their fingers. This allows them to feel for hard knots or tough bands of tissue beneath the skin. They can assess whether these structures are firm, how deeply they extend, and whether they cause tenderness when touched. The tissue affected by Dupuytren’s contracture feels distinctly different from normal palm tissue—much firmer and less flexible.[9]
A key diagnostic tool is the tabletop test, a simple yet revealing assessment. Your doctor will ask you to place your palm flat on a table or other flat surface, attempting to straighten all your fingers completely. If you cannot fully flatten your hand—meaning there’s a gap between your palm or fingers and the table surface—this strongly suggests the presence of contracture. This test helps quantify how much the condition is affecting your hand function.[4]
Your healthcare provider will assess which fingers are affected and to what degree. The ring finger and little finger are most commonly involved, followed by the middle finger. The index finger and thumb are rarely affected. Understanding this pattern helps confirm the diagnosis and distinguish Dupuytren’s contracture from other hand conditions.[2]
The examination includes checking the joints in your affected fingers. Your doctor will evaluate the metacarpophalangeal joint (where the finger meets the palm) and the proximal interphalangeal joint (the middle joint of the finger) to see how much they can bend and straighten. This assessment helps determine the severity of contracture and guides treatment decisions.[7]
It’s important to distinguish Dupuytren’s contracture from other conditions that can cause similar symptoms. Your doctor will rule out trigger finger, a condition where fingers catch or lock when you bend them but can be “popped” back into place. Unlike trigger finger, fingers affected by Dupuytren’s contracture cannot be manually straightened beyond a certain point. Similarly, arthritis causes joint swelling and different patterns of stiffness, whereas Dupuytren’s contracture involves the tissue layer beneath the skin rather than the joints themselves.[4]
Calluses, which are hardened, rough areas of skin on the palms, might also be confused with early Dupuytren’s contracture. However, calluses remain on the skin’s surface and don’t involve the deeper tissue layers that characterize Dupuytren’s. A ganglion cyst appears as a soft, moveable lump on the wrist or finger joints, quite different from the firm, fixed nodules of Dupuytren’s contracture.[5]
In most cases, additional testing beyond physical examination is unnecessary. Your medical history and the appearance and feel of your hands provide enough information for accurate diagnosis. Other tests are rarely required, making the diagnostic process relatively simple and non-invasive for most patients.[9]
However, in certain situations, your healthcare provider might recommend imaging studies. An ultrasound scan can visualize the nodules and cords beneath the skin, helping to assess their size and extent. This imaging technique uses sound waves to create pictures of soft tissues and is particularly useful for monitoring changes over time or evaluating the effectiveness of treatments. X-rays, on the other hand, are not typically helpful for diagnosing Dupuytren’s contracture because the condition affects soft tissues rather than bones.[6]
Your doctor will also take a detailed medical history, asking about your family background, ancestry, lifestyle factors, and any existing health conditions. This information helps establish risk factors and provides context for understanding how the condition might progress in your particular case.[2]
Diagnostics for Clinical Trial Qualification
When patients are being considered for participation in clinical trials testing new treatments for Dupuytren’s contracture, the diagnostic process becomes more standardized and detailed. Clinical trials require specific entry criteria to ensure that participants have a confirmed diagnosis and that researchers can accurately measure treatment outcomes.
The primary diagnostic criterion for clinical trial enrollment typically involves demonstrating the presence of measurable contracture. Researchers often use the tabletop test as a standardized assessment tool. Participants must show inability to place their hand completely flat on a table, indicating that cord tissue has caused finger contracture. This objective measure helps ensure that trial participants have disease severity appropriate for testing the intervention being studied.[4]
Clinical trials frequently specify which fingers and joints can be treated. Most studies focus on contractures affecting the metacarpophalangeal joint or the proximal interphalangeal joint, as these are the most commonly involved. Trials may require that contracture reach a minimum degree of severity—for example, the finger joint must be bent at least 20 degrees from straight—to qualify for enrollment. These criteria ensure that the treatment being tested has a meaningful contracture to work on.[7]
Physical examination remains the cornerstone of qualification assessment for clinical trials. However, researchers may use more precise measurement tools than typical clinical practice. They might use specialized instruments called goniometers to measure the exact angle of finger contracture at different joints. These measurements are recorded at the beginning of the trial and at regular intervals throughout, allowing researchers to quantify exactly how much improvement or change occurs with treatment.
For trials testing injectable treatments, such as enzyme injections that break down the collagen cords, researchers need to identify and locate the specific cord causing contracture. This involves careful palpation to feel the cord’s position, thickness, and extent. The presence of a clearly palpable cord that can be precisely targeted is often a requirement for enrollment in these studies.[13]
Ultrasound imaging may be incorporated into clinical trial diagnostic protocols more routinely than in standard clinical practice. Ultrasound can measure nodule size and hardness objectively, providing quantitative data that researchers can track over time. This is particularly important for trials testing treatments for early-stage disease, where the primary outcomes involve changes in nodule characteristics rather than finger straightening.[11]
Clinical trials often have strict exclusion criteria to protect participant safety and ensure reliable results. Diagnostic evaluation for trial enrollment includes screening for conditions that might interfere with treatment or increase risk. For example, trials testing needle procedures or enzyme injections might exclude patients taking blood-thinning medications due to increased bleeding risk. Patients with certain skin conditions affecting the hand, previous surgical treatment in the same finger, or allergic reactions to trial medications would typically be excluded based on diagnostic findings.[9]
Some trials require documentation of disease progression before enrollment. This might involve comparing current measurements with previous examinations or asking patients to demonstrate that contracture has worsened over a specific time period. This criterion helps identify patients with active, progressive disease who are most likely to benefit from intervention.
Blood tests or other laboratory work are not typically required specifically for diagnosing Dupuytren’s contracture in clinical trials. However, trials may require general health screening tests to ensure participants can safely undergo the experimental treatment. These might include basic blood counts, liver and kidney function tests, or tests for infectious diseases, depending on the treatment being studied.
Documentation requirements for clinical trials are more extensive than routine clinical care. Researchers create detailed records including photographs of the affected hand, precise measurements of all finger joints, mapping of nodule and cord locations, and assessments of hand function. This comprehensive documentation allows researchers to track changes systematically and compare results across different participants and treatment groups.






